DE69331331T2 - Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide - Google Patents

Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide

Info

Publication number
DE69331331T2
DE69331331T2 DE69331331T DE69331331T DE69331331T2 DE 69331331 T2 DE69331331 T2 DE 69331331T2 DE 69331331 T DE69331331 T DE 69331331T DE 69331331 T DE69331331 T DE 69331331T DE 69331331 T2 DE69331331 T2 DE 69331331T2
Authority
DE
Germany
Prior art keywords
binding peptides
inhibitoric
tolerogenic
immuno
carbohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331331T
Other languages
English (en)
Other versions
DE69331331D1 (de
Inventor
D Heerze
D Armstrong
Richard Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALBERTA RESEARCH COUNCIL INC., EDMONTON, ALBERTA,
Original Assignee
Alberta Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/995,503 external-priority patent/US5453272A/en
Application filed by Alberta Research Council filed Critical Alberta Research Council
Application granted granted Critical
Publication of DE69331331D1 publication Critical patent/DE69331331D1/de
Publication of DE69331331T2 publication Critical patent/DE69331331T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
DE69331331T 1992-10-02 1993-10-04 Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide Expired - Fee Related DE69331331T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95604392A 1992-10-02 1992-10-02
US07/995,503 US5453272A (en) 1992-10-02 1992-12-21 Lectin derived carbohydrate binding-peptide
PCT/CA1993/000415 WO1994007517A1 (en) 1992-10-02 1993-10-04 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides

Publications (2)

Publication Number Publication Date
DE69331331D1 DE69331331D1 (de) 2002-01-24
DE69331331T2 true DE69331331T2 (de) 2002-08-14

Family

ID=27130371

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331331T Expired - Fee Related DE69331331T2 (de) 1992-10-02 1993-10-04 Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide

Country Status (9)

Country Link
US (5) US5736143A (de)
EP (1) EP0666758B1 (de)
JP (1) JPH08501569A (de)
AT (1) ATE210452T1 (de)
AU (1) AU686116B2 (de)
CA (1) CA2145881C (de)
DE (1) DE69331331T2 (de)
ES (1) ES2169724T3 (de)
WO (1) WO1994007517A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007517A1 (en) 1992-10-02 1994-04-14 Alberta Research Council Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
IL111866A (en) * 1994-12-04 2005-03-20 Yeda Res & Dev Pharmaceutical compositions comprising the b-oligomer of pertussis toxin
EP1073459A4 (de) * 1998-04-27 2005-01-19 Biocrystal Ltd Zusammensetzungen und methoden zur tolerierung in immunkomplex-vermittelten krankheitsverläufen
US6638518B1 (en) * 1999-02-22 2003-10-28 University Of Iowa Research Foundation Method for inhibiting inflammatory responses
KR100428469B1 (ko) 2001-04-17 2004-04-27 한국과학기술연구원 강한 결합력을 가지는 당 특이적 펩타이드 및 그의 제조방법
US20030033413A1 (en) * 2001-06-19 2003-02-13 Willson Alan N. Mobile wireless local area network
US20050026866A1 (en) * 2002-08-02 2005-02-03 Pawelek John M. Agents and methods for treatment of disease by oligosaccharide targeting agents
US20040072992A1 (en) * 2002-08-30 2004-04-15 Sachiko Machida Novel peptide capable of specifically acting on biological membrane
EP1746902A4 (de) * 2004-05-05 2007-06-13 Univ Northeastern Multilektin-affiniätschromatografie und verwendung dafür
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
US9169327B2 (en) 2008-03-12 2015-10-27 Rowan University Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
CN102215871B (zh) * 2008-09-12 2016-06-29 圣安德鲁斯大学董事会 糖结合分子
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3096791B1 (de) 2014-01-24 2023-12-20 Pneumagen Ltd. Immunmodulierende verbindungen
US11043823B2 (en) * 2017-04-06 2021-06-22 Tesla, Inc. System and method for facilitating conditioning and testing of rechargeable battery cells
WO2020074984A1 (en) * 2018-09-16 2020-04-16 Unichem Laboratories Ltd Protein for treatment of inflammatory diseases

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
US5157023A (en) * 1984-08-21 1992-10-20 Lipton James M Antipyretic and anti-inflammatory lys pro val compositions and method of use
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US5244657A (en) * 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
AU631351B2 (en) * 1988-04-20 1992-11-26 Massachusetts Health Research Institute, Inc. (Mhri) Pertussis toxoid vaccine
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
US5198424A (en) * 1989-03-08 1993-03-30 Board Of Regents Of The University Of Oklahoma Functionally active selectin-derived peptides
DK0436726T3 (da) * 1989-08-03 1993-12-27 Eisai Co Ltd Fotostabil oftalmisk opløsning og fremgangsmåde til fremstilling deraf
DE3926912A1 (de) * 1989-08-16 1991-02-21 Bosch Gmbh Robert Elektromagnetischer drehsteller
CA2069622A1 (en) 1989-11-29 1991-05-30 Camille Locht Vaccine
JPH05503512A (ja) * 1989-11-29 1993-06-10 ブリガム・アンド・ウイメンズ・ホスピタル 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
US5196511A (en) * 1989-12-01 1993-03-23 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding
AU8007791A (en) * 1990-06-15 1992-01-07 Cytel Corporation Intercellular adhesion mediators
DE69133120T2 (de) 1990-07-17 2003-05-15 Univ Oklahoma Norman Board Of GMP-140 Ligand
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
NZ240316A (en) * 1990-10-25 1996-12-20 Univ Michigan Compound for treating disease mediated by the elaboration of elam-1 on endothelial cells
IE914075A1 (en) * 1990-11-23 1992-06-03 Gen Hospital Corp Inhibition of cell adhesion protein-carbohydrate¹interactions
WO1992011612A1 (en) * 1990-12-21 1992-07-09 Minnesota Mining And Manufacturing Company Two-channel xor bar code and optical reader
EP0575557A1 (de) * 1991-03-11 1993-12-29 New England Medical Center Verfahren zur hemmung von padgem-vermittelter interaktionen unter verwendung von einer 2,6-sialinsäure
AU667813B2 (en) * 1991-05-03 1996-04-18 Rockefeller University, The Amino-acid sequence homologies between selectins and B pertussis toxin-peptides derived therefrom antibodies thereto pharmaceutical compositions
US5374655A (en) * 1991-06-10 1994-12-20 Alberta Research Council Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
DE69329333D1 (de) * 1992-03-20 2000-10-05 Cor Therapeutics Inc Durch glykosylierung vermittelte hemmung des faktors x
US5440015A (en) * 1992-07-21 1995-08-08 Glycomed Incorporated Selectin peptide medicaments for treating disease
WO1994007517A1 (en) * 1992-10-02 1994-04-14 Alberta Research Council Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
US5496934A (en) * 1993-04-14 1996-03-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acids encoding a cellulose binding domain
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
IL111866A (en) * 1994-12-04 2005-03-20 Yeda Res & Dev Pharmaceutical compositions comprising the b-oligomer of pertussis toxin
US5858965A (en) * 1994-12-04 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits

Also Published As

Publication number Publication date
AU686116B2 (en) 1998-02-05
US20020054880A1 (en) 2002-05-09
ES2169724T3 (es) 2002-07-16
US5833990A (en) 1998-11-10
EP0666758A1 (de) 1995-08-16
CA2145881C (en) 2000-12-19
JPH08501569A (ja) 1996-02-20
WO1994007517A1 (en) 1994-04-14
US6245883B1 (en) 2001-06-12
US5747040A (en) 1998-05-05
ATE210452T1 (de) 2001-12-15
CA2145881A1 (en) 1994-04-14
EP0666758B1 (de) 2001-12-12
US5736143A (en) 1998-04-07
AU5105693A (en) 1994-04-26
DE69331331D1 (de) 2002-01-24

Similar Documents

Publication Publication Date Title
DE69331331T2 (de) Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
TR199901571T2 (xx) T�berk�lozun imm�noterapi te�hisi i�in bile�ikler ve y�ntemler.
NO962346L (no) Humaniserte antistoffer og anvendelser derav
GR1001550B (el) Αλατα βασικών πεπτιδίων με πολυεστέρες που έχουν ακραία ομάδα καρβοξύ.
DE60019458D1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
TR200000115T2 (tr) Tüberkülozun immünoterapi ve teşhisi için bileşikler ve bu bileşiklerin kullanımı için yöntemler.
ATE388165T1 (de) Menschliches cnp-gen und vorläuferprotein
IT1244548B (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ATE193022T1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
DE68927379T2 (de) Plättchen blockierende peptide
DE68925275T2 (de) Endotoxin-bindeprotein und dessen verwendung
DE69317435T2 (de) Entzündungshemmende tolerogene und inmonoinhibitorische eigenschaften von karbohyhydrate bindenden peptiden
ATE326981T1 (de) Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
HUP9904199A1 (hu) Egyláncú anti-p53 antitest fragmentumok és alkalmazásuk
ITMI930456A0 (it) Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis
DK0639225T3 (da) Nye polypeptider og peptider, nucleinsyrer, der koder for dem, og deres anvendelse i området tumorterapi, inflammation eller immunologi
DK0755407T3 (da) Farmaceutisk peptidformuleringer til behandling af stövmideallergi
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ALBERTA RESEARCH COUNCIL INC., EDMONTON, ALBERTA,

8339 Ceased/non-payment of the annual fee